Azacarbazole n-3 and n-6 polyunsaturated fatty acids ethyl esters nanoemulsion with enhanced efficacy against
Azacarbazoles
Flax oil
Malaria
Nanoemulsion
P. falciparum
n-3 and n-6 polyunsaturated fatty acids ethyl esters
Journal
Bioactive materials
ISSN: 2452-199X
Titre abrégé: Bioact Mater
Pays: China
ID NLM: 101685294
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
29
05
2020
revised:
27
09
2020
accepted:
07
10
2020
entrez:
2
11
2020
pubmed:
3
11
2020
medline:
3
11
2020
Statut:
epublish
Résumé
Alternative therapies are necessary for the treatment of malaria due to emerging drug resistance. However, many promising antimalarial compounds have poor water solubility and suffer from the lack of suitable delivery systems, which seriously limits their activity. To address this problem, we synthesized a series of azacarbazoles that were evaluated for antimalarial activity against D10 (chloroquine-sensitive) and W2 (chloroquine-resistant) strains of
Identifiants
pubmed: 33134609
doi: 10.1016/j.bioactmat.2020.10.004
pii: S2452-199X(20)30255-3
pmc: PMC7588843
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1163-1174Informations de copyright
© 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
Déclaration de conflit d'intérêts
None.
Références
Chem Soc Rev. 2014 Oct 7;43(19):6716-26
pubmed: 24514864
Malar J. 2018 Apr 2;17(1):133
pubmed: 29606144
J Colloid Interface Sci. 2007 Oct 1;314(1):230-5
pubmed: 17612555
J Control Release. 2016 Jul 10;233:88-100
pubmed: 27155364
Sci Pharm. 2017 Mar 31;85(2):
pubmed: 28362322
ACS Med Chem Lett. 2013 Sep 22;4(11):1037-41
pubmed: 24900603
Food Chem Toxicol. 2014 Oct;72:40-50
pubmed: 25016034
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17010-5
pubmed: 23027934
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11865-70
pubmed: 8876229
Artif Cells Nanomed Biotechnol. 2015;43(5):334-44
pubmed: 24641773
Anticancer Agents Med Chem. 2015;15(8):1049-65
pubmed: 25584693
Chem Rev. 2012 Jun 13;112(6):3193-328
pubmed: 22480243
J Inorg Biochem. 2008 May-Jun;102(5-6):1288-99
pubmed: 18226838
J Protozool. 1965 Nov;12(4):563-76
pubmed: 5860234
Blood. 1968 Nov;32(5):811-5
pubmed: 5687939
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4294-4297
pubmed: 28843708
Eur J Med Chem. 2018 Jul 15;155:579-589
pubmed: 29913383
Arch Immunol Ther Exp (Warsz). 1986;34(3):327-31
pubmed: 3296992
Int J Nanomedicine. 2014 Aug 11;9:3865-74
pubmed: 25143734
Int J Infect Dis. 2014 Dec;29:268-73
pubmed: 25448338
Nature. 2002 Feb 7;415(6872):686-93
pubmed: 11832957
Bioorg Med Chem. 2012 Oct 1;20(19):5980-5
pubmed: 22901673
Int J Nanomedicine. 2015 Feb 20;10:1493-503
pubmed: 25759576
Biotechnol Prog. 2006 Jan-Feb;22(1):186-98
pubmed: 16454510
J Clin Invest. 1980 Oct;66(4):856-8
pubmed: 7419723
Curr Pharm Biotechnol. 2011 Dec;12(12):1983-90
pubmed: 21554220
Molecules. 2019 May 17;24(10):
pubmed: 31109016
Mem Inst Oswaldo Cruz. 2013 Jun;108(4):501-7
pubmed: 23827996
J Pharm Sci. 2008 Aug;97(8):2924-35
pubmed: 17973307
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Antimicrob Agents Chemother. 2009 Oct;53(10):4339-44
pubmed: 19651905
J Biol Chem. 2010 Oct 22;285(43):33054-64
pubmed: 20702404
Am J Trop Med Hyg. 1993 Feb;48(2):205-10
pubmed: 8447524
Drug Dev Ind Pharm. 2017 Nov;43(11):1743-1758
pubmed: 28673096
Prog Lipid Res. 2008 Jan;47(1):50-61
pubmed: 18023422
Future Microbiol. 2009 May;4(4):441-55
pubmed: 19416013
Bioorg Med Chem. 2005 Sep 15;13(18):5338-45
pubmed: 16054368
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
J Clin Invest. 1992 Mar;89(3):961-7
pubmed: 1541684
Acta Trop. 2019 Jul;195:103-114
pubmed: 31039335
Molecules. 2014 Jul 02;19(7):9307-17
pubmed: 24991761
J Colloid Interface Sci. 2016 Feb 1;463:258-65
pubmed: 26550783
FEBS Lett. 2011 Jun 6;585(11):1551-62
pubmed: 21530510
J Cell Biol. 1985 Mar;100(3):965-73
pubmed: 3972906
Nanomedicine (Lond). 2018 May;13(10):1139-1155
pubmed: 29873597
J Med Chem. 2016 Jul 14;59(13):6344-52
pubmed: 27312008
J Antimicrob Chemother. 2017 Nov 1;72(11):3122-3130
pubmed: 28981899
Nat Prod Commun. 2013 Aug;8(8):1135-6
pubmed: 24079187
Int J Nanomedicine. 2014 Nov 20;9:5373-87
pubmed: 25484584
Acta Pol Pharm. 1962;19:229-42
pubmed: 14478332
Acta Pol Pharm. 1966;23(4):331-7
pubmed: 5959374
Cell Biol Toxicol. 2005 Jan;21(1):1-26
pubmed: 15868485
Biol Pharm Bull. 2012;35(9):1432-9
pubmed: 22975492
Parasitol Today. 1986 Dec;2(12):330-1
pubmed: 15462754
Eur J Pharm Biopharm. 2012 Apr;80(3):528-34
pubmed: 22142592
N Engl J Med. 2009 Jul 30;361(5):455-67
pubmed: 19641202
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1304-18
pubmed: 26666937
AAPS PharmSciTech. 2007 Dec 14;8(4):E104
pubmed: 18181525
Chem Rev. 2002 Nov;102(11):4303-427
pubmed: 12428991
N Engl J Med. 2014 Jul 31;371(5):411-23
pubmed: 25075834
Int J Pharm. 2008 Oct 1;362(1-2):172-8
pubmed: 18611435
Int J Pharm. 2008 Jan 22;347(1-2):136-43
pubmed: 17709216
Biochim Biophys Acta. 1983 Jul 13;732(1):316-9
pubmed: 6871197
Int J Parasitol Drugs Drug Resist. 2017 Aug;7(2):191-199
pubmed: 28395189
Int J Pharm. 2012 Jul 15;431(1-2):149-60
pubmed: 22265913
Blood. 2013 Feb 21;121(8):1276-84
pubmed: 23264591
Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):325-9
pubmed: 1988933
Pol J Pharmacol Pharm. 1981 Jan-Feb;33(1):121-7
pubmed: 7255278
Exp Parasitol. 2012 Jul;131(3):292-9
pubmed: 22561991
Eur J Med Chem. 2015 Apr 13;94:405-26
pubmed: 25794500
Int J Pharm. 2008 Oct 1;362(1-2):179-83
pubmed: 18652886
FEBS J. 2007 Sep;274(18):4688-98
pubmed: 17824955
Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):560-75
pubmed: 19914313
Nanomaterials (Basel). 2017 Oct 26;7(11):
pubmed: 29072633
Adv Colloid Interface Sci. 2013 Dec;201-202:1-17
pubmed: 24192063
Mini Rev Med Chem. 2016;16(8):630-43
pubmed: 26156543
Bioorg Med Chem. 2013 Nov 15;21(22):7165-74
pubmed: 24095011
J Control Release. 2002 May 17;81(1-2):65-74
pubmed: 11992679
Science. 1976 Aug 20;193(4254):673-5
pubmed: 781840
Malar J. 2011 Apr 11;10:85
pubmed: 21481272